Kilat, Alexandria .

HRN: 21-38-26  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2024
CEFTRIAXONE 1G (VIAL)
05/11/2024
05/18/2024
IVT
2g
Q24h
Appendicitis
Waiting Final Action 
05/11/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/11/2024
05/18/2024
IVT
500 Mg
Q8h
Appendicitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: